DreaMed gets FDA approval for diabetes management software Ruby Khatun Khatun20 Jun 2018 9:30 AM ISTTEL AVIV: Israel’s DreaMed Diabetes said the U.S. Food and Drug Administration (FDA) has approved for marketing its Advisor Pro software to help...
Lupin expects single digit sales growth this fiscal Ruby Khatun Khatun19 Jun 2018 10:30 AM ISTNew Delhi: Drug maker Lupin expects single-digit sales growth this fiscal with sluggish US business likely to impact the overall global business of...
Indian-American indicted for multi-million dollar pharma fraud scheme in US Medical Dialogues Bureau19 Jun 2018 10:00 AM ISTAn Indian-American former president of a blood-testing company along with its founder has been charged in the US for allegedly engaging in a...
FDA declines to approve Valeant's plaque psoriasis lotion Ruby Khatun Khatun19 Jun 2018 9:45 AM ISTValeant Pharmaceuticals International Inc’s plaque psoriasis treatment did not get approval from U.S. health regulators, a setback for the company...
Novartis touts effectiveness, safety of autoimmune drug copies Medical Dialogues Bureau19 Jun 2018 9:30 AM ISTZURICH: Novartis touted safety and efficacy of its biosimilar copies of Johnson & Johnson's Remicade and Amgen Inc's Enbrel, citing a study it...
NCLT allows Fortis to withdraw amalgamation scheme Ruby Khatun Khatun18 Jun 2018 11:05 AM ISTNew Delhi: Fortis Healthcare said National Company Law Tribunal (NCLT) bench in Chandigarh has approved the withdrawal of the scheme of amalgamation...
Alembic Pharma receives EIR from USFDA Medical Dialogues Bureau18 Jun 2018 10:30 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals said it has received Establishment Inspection Report from the US health regulator for its formulation...
Bayer begins Rs 1.3K crore open offer process to buy up to 26 percent stake in Monsanto India Medical Dialogues Bureau18 Jun 2018 10:00 AM ISTGerman chemicals and pharma major Bayer group has launched the process for over Rs 1,300 crore open offer to acquire up to 26 percent additional stake...
Sanofi says on track to regain solid position in cancer drugs Ruby Khatun Khatun18 Jun 2018 9:30 AM ISTSanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market on the back of its immunotherapy...
Cipla gets USFDAs final approval for generic Isuprel Medical Dialogues Bureau17 Jun 2018 1:34 PM ISTMumbai: Cipla, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection...
Eli Lilly lupus treatment succeeds in mid-stage trial Ruby Khatun Khatun17 Jun 2018 10:41 AM ISTEli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger...
Sanofi Plots Cancer Comeback With First New Drug in Years Medical Dialogues Bureau17 Jun 2018 10:41 AM ISTBloomberg: Sanofi was a spectator during the last wave of cancer breakthroughs. The French drugmaker is counting on its first new tumor drug in seven...
